Cargando…
Glioma and microenvironment dual targeted nanocarrier for improved antiglioblastoma efficacy
Drug delivery systems based on nanoparticles (nano-DDS) have aroused attentions for the treatment of glioblastoma (GBM), the most malignant brain cancer with a dismal prognosis. However, there are still numerous unmet challenges for traditional nano-DDS, such as the poor nanoparticle penetration, sh...
Autores principales: | Wang, Xiuzhen, Zhang, Qing, Lv, Lingyan, Fu, Junjie, Jiang, Yan, Xin, Hongliang, Yao, Qizheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241031/ https://www.ncbi.nlm.nih.gov/pubmed/28933201 http://dx.doi.org/10.1080/10717544.2017.1378940 |
Ejemplares similares
-
Chemically Modified Variants of Fenofibrate with Antiglioblastoma Potential()()
por: Stalinska, J., et al.
Publicado: (2019) -
CRY2 isoform selectivity of a circadian clock modulator with antiglioblastoma efficacy
por: Miller, Simon, et al.
Publicado: (2022) -
Review of Natural Product-Derived Compounds as Potent Antiglioblastoma Drugs
por: Park, Moon Nyeo, et al.
Publicado: (2017) -
Improved Antiglioblastoma Activity and BBB Permeability by Conjugation of Paclitaxel to a Cell‐Penetrative MMP‐2‐Cleavable Peptide
por: Hua, Dan, et al.
Publicado: (2020) -
Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data
por: Cheng, H-W, et al.
Publicado: (2015)